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ABSTRACT 
 
Background- Climacteric is the phase in the ageing of women marking the transition from the reproductive phase to the non 
reproductive state. According to a survey, 44% of post menopausal women used hormonal replacement therapy (HRT). Aim: 
The present analysis is of the cases prescribed with Sepia officinalis to evaluate its efficacy in DDCY. Method- An open 
prospective observational study was undertaken by a research institute at six centers for a period of 4 years (including a 
follow up period of 1 year) as per the protocol. The cases where Sepia (n=53) was found indicated and prescribed were taken 
up for analysis. The data was analyzed statistically by using the “Wilcoxon sign rank test” on SPSS for the symptoms score 
and gynecological findings and “t test” for laboratory findings. Results- The mean symptom score at the base line was 13.68 
(4.27) and at the end of treatment was 2.81 (2.63), which is statistically significant (P<0.05). Out of 53 patients who 
completed their follow up, 37 patients showed marked improvement, 14 patients showed moderate improvement and 2 
patients showed mild improvement. Forty (40) patients were investigated for FSH both at entry and completion, the FSH 
value reduced in 24cases. Out of 15 patients who were investigated for lipid profile on completion of the study, the level of 
lipid cholesterol and Triglycerides (TG) were reduced in 6 patients, HDL was increased in 12 patients which is statistically 
significant (P=0.024), LDL was decreased in 8 cases and VLDL was decreased in 7 cases. Conclusion-Results of the analysis 
showed the usefulness of Sepia in management of distress during climacteric years. Further RCT are being conducted to 
validate the effectiveness of Sepia in DDCY. 
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epia officinalis is an animal remedy made from the 
ink of the cuttlefish [1]. The cuttle-fish inhabits the 
seas of Europe, especially the Mediterranean. Sepia 
in a dry state appears to be a dark blackish-brown, solid 
mass, of shining, very brittle fracture, having a faint smell 
of seafish. The cuttle-fish is without an external shell, one 
to two feet long, soft-gelatinous, of a brown color verging 
on red, and spotted black [2]. Sepia officinalis is one of the 
most important woman‟s remedy in homoeopathy used for 
gynecological disorder [1].Within world of homoeopathy, 
Sepia officinalis has been recognized as one of the 20 
remedies that have widest range of application. In 1834, 
Sepia officinalis was discovered as potential homoeopathic 
remedy. Sepia can work on issues related to uterus, vagina, 
and ovaries. It may work for symptoms of hot flushes 
experienced during menopause [3]. 
Climacteric period in the aging woman is the transition 
from the reproductive phase to non reproductive state. In 
this period, woman of age around 40-55 years presents the 
symptoms like hot flushes, night sweat and mood swings, 
dysuria, pruritus vulva. These are the symptoms which are 
felt by the menopausal woman. Homoeopathic literature 
reveals that Sepia officinalis is a very good medicine for 
Distress During Climacteric Years (DDCY), if prescribed 
on the totality of symptoms of patients. The homeopathic 
remedy Sepia officinalis is prepared from unadulterated 
pigments of the ink enclosed in the cuttlefish‟s ink sac. 
The pure brownish-grey ink obtained from the cuttlefish‟s 
S 
Gupta & Das                                          Sepia officinalis for Management of Distress during Climacteric Years  
Vol 1|Issue 1| Oct-Dec 2019                                                                                           Indian J Integrative Med 15 
ink sac forms the basis of this medication. Soon after the 
ink is obtained from the cuttlefish, it is dehydrated and 
succussed. Subsequently, the dried ink is profusely diluted 
till the desired levels are attained by adding huge amounts 
of milk sugar (lactose). The resultant solution is the 
homeopathic remedy sepia, which does not retain any trace 
of ink and is safe for human use [4]. The pure, powdered 
sepia is covered with five parts by weight of dilute alcohol, 
poured into a well-stopper bottle, and allowed to remain 
eight days in a dark, cool place, being shaken twice a day. 
The tincture is then poured off, strained and filtered. 3 
Hahnemann, with five others, first proved Sepia, and it 
was reproved by the American Institute [5].  The present 
analysis is of the cases prescribed with Sepia officinalis to 
evaluate its efficacy in DDCY. 
METHODS 
The study was conducted as an open observational study 
by a tertiary care institute at six centers (including a follow 
up period of 1 year). Clearance by the ethical committee 
was obtained before initiation of the study. The study was 
verbally explained to each patient with the help of patient 
information sheet printed in regional language and 
thereafter a written informed consent was obtained from 
the patients. Female patients between the ages of 40 and 55 
years and with changes in menstrual pattern or with 
cessation of menstruation for at least 1 year were screened 
from the general outpatient department of the 
institutes/units. The inclusion criteria were female with 
cessation of menstruation for at least 1 year with FSH level 
>40 mlU/ml or women in the perimenopausal period with 
serum FSH ranging between 10 and 40 mlU/mL on the 
second day of menstrual cycle. The patients who had an 
artificial menopause and were on HRT, had a history of 
breast or reproductive organ cancer, uncontrolled HTN, 
DM, Chronic Renal failure and severe psychiatric 
disturbance based on history, relevant investigation or 
physical examination, were excluded.  
As the study was done at six centers, a uniform 
questionnaire Distress during climacteric years symptoms 
scale (DDCYSS) was devised by the council to remove the 
bias of the investigator for assessing the individual 
symptoms. The cases which were prescribed with Sepia 
officinalis were taken from the above study and analyzed. 
It was found that Sepia was one of the most effective 
medicines in the management of DDCY. At entry, an 
objective assessment of 15 predefined symptoms 
menopause was done on DDCYSS. Each symptom in 
DDCYSS was quantified considering its frequency, 
duration and intensity by attributing scores 0-4. Also every 
patient was subjected to per vaginal examination as 
required at the base line. After the first visit, follow up was 
done every week for a month, then every 2 weeks for 3 
months and then monthly for 8 months. Evaluation of 
symptoms was done as per DDCYSS at every follow up 
and per vaginal examination was done at the 3rd, 6th, 9th, 
and 12th month. The patients were followed up for a 
period of 1 year.  
Following a detailed homoeopathic consultation with 
assessment of signs and symptoms, each patient was 
treated with individualized homoeopathic medicine after 
repertorization on CARA software in final consultation 
with material medical based on homoeopathic principle. 
Total fifty three (53) cases were prescribed with Sepia 
officinalis, single dose in 30C potency, 4 pills (size 30) on 
empty stomach. Medicine was repeated first in the same 
potency and subsequently in higher potencies as per the 
need of the case. Some of the important features of Sepia 
in relation to our study are given below. 
 Some of the characteristic indications of patients 
prescribed with Sepia officinalis are as follows: 
 Indifference towards family, relatives 
 Becomes angry on contradiction    
 Changeable mood; Overanxious; Oversensitive, 
Weeps easily; Desires Company; Forgetfulness 
 Irritability on consolation 
 Becomes irritable when disturbed  
 In general, aggravates in the morning  
 Hot flushes worse from exertion; Hot flushes with 
perspiration 
 Tendency to catch cold 
 Aversion to milk; Desires sweets; Desires cold 
drinks; aggravation from fatty food 
 General weakness, palpitation 
 Diminished appetite  
 Perspiration – scanty; Offensive perspiration  
 Sour taste in the mouth  
 Menses copious during menopause 
 Leucorrhoea – thin; Leucorrhoea < morning 
 Vaginal pain worse during coition 
 Leucorrhoea white 
 Burning pain in the soles; Dryness of the soles; 
Sensation of lump in the throat; Right sided 
headache; Sudden urging for urination; Paleness 
of skin 
The data were analysed statistically by using the 
“Wilcoxon sign rank test” on SPSS software for the 
symptoms score and gynaecological findings and “t test” 
for laboratory findings. After completion of treatment for 
one year period, the outcome was assessed by using the 
following formula. 
 
%improvement= Score at entry-Score at Completion X100 
                              Score at entry 
 
Accordingly, improvement indices were formulated as 
marked improvement (75% or more improvement in 
symptoms score from baseline score), moderate 
improvement (50% to 75% improvements from baseline 
score), mild improvement (25% to <50% improvement 
from baseline score) and no significant improvement 
(<25% improvement from baseline score).  
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RESULTS 
In the study period, 53 patients were prescribed with Sepia 
officinalis on the basis of totality of symptoms through 
repertorization and followed up for 1 year. The mean age 
of Sepia patients in this analysis was found to be 46.87 
years (Table 1).  
Table 1: Demographic and Baseline Data 
Age profile No (%) Mean(SD) 
40-50 years 44(83.0) 
46.87(4.04) 
50-60 years 9(17.0) 
Intensity 
Mild(4-11) 17(32.1) 8.6(1.5) 
Moderate(12-24) 36(67.9) 16.0(2.9) 
Severe(25-36) 0 0 
Symptoms No (%) Median (IQR) 
Hot Flushes 49(92.4) 1(1 to 2.5) 
Night sweats 45(84.9) 1(1 to 2) 
Anxiety 48(90.5) 1(1 to 2) 
Depression 37(69.8) 1(1 to 1.5) 
Palpitation 41(77.3) 1(1 to 1) 
Pruritis vulvae 18(33.9) 0(0 to 1) 
Dysuria 19(35.5) 0(0 to 1) 
Sexual desire (change 
from previous) 30(56.6) 1(0 to 2) 
Poor memory 44(83.0) 1(1 to 2) 
Stress 28(52.8) 1(0 to 1) 
Dyspareunia 11(20.7) 0(0 to 0) 
Vaginal dryness 15(28.3) 0(0 to 1) 
Discharge per vagina 28(52.8) 1(0 to 1) 
Insomnia 31(58.4) 1(0 to 1) 
Work & activities affected 46(86.7) 1(1to 2) 
Total symptom score‡ 53(100) 13.68(4.27)‡ 
‡Express in terms of Mean (SD) 
The intensity of menopausal distress was assessed through 
baseline symptom score at entry as per the DDCYSS. 
Seventeen (17) participants having baseline score between 
4 and11 were classified as mild, 36 participants having a 
baseline score between 12and 24 were classified as 
moderate. It was found that at completion, 2 patients were 
having moderate intensity of symptoms and 51 participants 
were having mild intensity of symptoms (patients with 
symptom score less than 4 at completion were also 
included in mild category). The DDCY Symptoms Score 
was used to assess the patient‟s condition from baseline up 
to 1 year (Table 2). The mean symptom score at the base 
line was 13.68(4.27) and at the end of treatment is 2.81 
(2.63) and it was found to be statistical significant 
(P<0.05) 
Table 2: Comparison of symptoms in DDCYSS with 
Pre-Post analysis 
Symptoms Median(IQR)score 
Z 
value p value at entry at end 
Hot Flushes 1( 1 to 2.5) 0(0 to 0.5 5.827 0.001* 
Night sweats 1(1 to 2) 0(0 to 0) 5.641 0.001* 
Anxiety 1(1 to 2) 0(0 to 0) 5.701 0.001* 
Depression 1( 1 to 1.5) 0(0 to 0) 5.209 0.001* 
Palpitation 1(1 to 1) 0(0 to 0) 5.777 0.001* 
Pruritis  
vulvae 0(0 to 1) 0(0 to 0) 3.499 0.001* 
Dysuria 0(0 to 1) 0(0 to 0) 4.119 0.001* 
Change in 
sexual desire 1(0 to 2) 0(0 to 0) 3.874 0.001* 
Poor memory 1(1 to 2) 0(0 to 1) 4.746 0.001* 
Stress 1(0 to 1) 0(0 to 0.5 4.347 0.001* 
Dyspareunia 0(0 to 0) 0(0 to 0) 2.714 0.007* 
Vaginal 
dryness 0(0 to 1) 0(0 to 0) 3.638 0.001* 
Discharge per 
vagina 1(0 to 1) 0(0 to 0) 4.625 0.001* 
Insomnia 1(0 to 1) 0(0 to 0) 4.083 0.001* 
Work & 
activities 
affected 1(1to 2) 0(0 to 1) 5.896 0.001* 
Total 
symptom 
score‡ 
13.68 
(4.27) 2.81(2.63) 21.62 0.001‡ 
* P value is significant at p<0.05 by using Wilcoxon sign 
rank test 
‡ P value is significant   at p<0.05 by using Paired t test 
Out of 53 patients who completed their follow up, 37 
patients showed marked improvement, 14 patients showed 
moderate improvement and 2 patients showed mild  
improvement. FSH reduced in 24 cases out of 40 cases that 
were investigated for FSH at the end of treatment. Out of 
15 patients who were investigated for lipid profile on 
completion of the study, the level of lipid cholesterol and 
Triglycerides (TG) were reduced in 6 patients, HDL was 
increased in 12 patients which is statistically significant 
(P=0.024), LDL was decreased in 8 cases and VLDL was 
decreased in 7 cases. Changes in FSH and lipid profiles are 
not statistically significant except HDL (Table 3). As 
regards gynecological findings, Cervicitis was found in 15 
cases and got markedly improved in 13 cases, which is 
statistically significant(P=0.005); Cervical erosion, 
Hypertrophied lip of cervix and Rectocele was found in 1 
case each and got markedly improved. Candid discharge  
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per vaginum was found in 11 cases and got markedly 
improved in 7 cases. Trichomonas vaginalis discharge was 
present in 9 cases and got improved in 5 cases. Retroverted 
uterus was found in 21 cases, and becamenormal in 13 
cases, which is statistically significant (P=0.004) (Table 4). 
Tenderness on examination was present in 10 cases, and 
was improved in 9 cases after treatment, which is 
statistically significant (P=0.011). There was fluid in the 
pouch of Douglas in 5 cases which got cleared in 4 cases. 
(Table – 5).  
Table 3: Statistical analysis of Laboratory Investigations at entry and at end 
Parameters  Entry End Mean difference 95% CI P value 
Mean(SD) Mean(SD) 
Serum FSH 62.2(44.5) 73.1(52.8) -10.8 -10.3 to 9.7 0.949 
Lipid cholesterol 189.1(33.9) 193.4(22.1) -4.3 -14.6 to 6.1 0.391 
TG 141.3(48.8) 140.3(41.7) 1.0 -22.7 to 24.8 0.927 
HDL 40.1(7.6) 47.9(7.1) -7.9 -14.6 to -1.2 0.024* 
LDL 119.4(29.7) 118.1(20.5) 1.4 -10.4 to 13.1 0.809 
VDL 27.5(10.9) 28.1(8.3) -0.5 -5.7 to 4.7 0.835 
* Statistically significant at p<0.05 
Table 4: Gynaecological findings 
Symptoms 
Median (IQR) 
Z value p value at entry at end 
Condition of Cervix 1(1 to 2) 1(1to1) 2.8 0.005* 
Nature of discharge 3(2 to 3) 3(2 to 3) 0.4 0.672 
Position of uterus 2(1 to 2) 1(1 to 1.7) 2.8 0.004* 
Tenderness 2(2to2) 2(2to2) 2.5 0.011* 
pouch of douglas 3(3to3) 3(3to3) 1.3 0.18 
Bleeding 2(2to2) 2(2to2) 1.4 0.157 
* P value is significant at p<0.05 by using Wilcoxon signed rank test 
Table 5: Gynaecological findings at baseline and at end of treatment 
Gynaecological examination  P/V & P/S findings Present at baseline (n) Improved at completion (n) 
Improved at 
completion (%) 
Condition of Cervix 
Cervicitis 15 13 86.66 
Cervical erosion 1 1 100 
Senile vaginitis 3 1 33.33 
Hypertrophied 1 1 100 
Nature of discharge 
Candid discharge 11 7 63.6 
TV discharge 9 5 55.5 
Position of uterus 
Retroverted 21 13 61.9 
Rectocele 1 1 100 
Cystocele 6 2 33.3 
Tenderness Present 10 9 90 
Pouch of Douglas Fluid 5 4 80 
Bleeding Present 5 2 40 
 
DISCUSSION 
In this analysis, it was observed that out of 53 patients, 37 
patients showed marked improvements, 14 patients 
showed moderate improvement, and 2 cases showed mild 
improvement. Sepia officinalis is a very good medicine for 
Distress During Climacteric Years (DDCY), if prescribed 
on the totality of symptoms of patients. It was found that 
Sepia when selected on the basis of presenting symptoms 
of menopause and characteristic attributes of the patient, 
improved the patients as a whole. On analyzing the 
additional data, it was found that cervicitis, cervical 
erosion, and rectocele were also improved. This is again a 
reconfirmation of the holistic tenet of Homoeopathy where 
a holistically selected similimum not only relieves the 
primary complaint of the patient but at the same time takes 
care of other problems as well. In the present day scenario 
with HRT scare, women are looking forward to safer and 
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effective options of treatment. This analysis reconfirms the 
scope of Sepia for effective management of menopausal 
complaints. 
In a study by Bordet et al [7] it was observed that Sepia 
was the medicines found frequently indicated and useful 
along with other medicines. This corroborates with our 
present analysis. Sepia and other medicines have been 
successfully used by homoeopathic practitioners for the 
treatment of menopausal distress syndrome [8-10]. Our 
analysis also supports findings of these studies. Sepia 
along with other medicines is also mentioned as first-grade 
medicines under the rubric “menopause” in the Synthesis 
Repertory [11]. In a pilot study [12] on “homoeopathic 
treatment for hot flushes”, Sepia was found as one of the 
most effective medicine. In a prospective observational 
study [13] on the “Homoeopathic approach to the 
treatment of symptoms of estrogen withdrawal in breast 
cancer patients”, Sepia was found as the one of the most 
effective medicine. All above mentioned studies 
corroborate with our analysis. 
As the homoeopathic system of medicine is based on 
individualization, it cannot be claimed beforehand that 
Sepia is the medicine for menopausal distress. if Sepia is 
indicated after repertorisation of the case and in final 
consultation with material medical then only Sepia can be 
prescribed. The another constraint was that follow up 
period of the cases was only for 1 year as per protocol 
[14], so no case could be labeled as „cured‟.  More period 
for the follow up of the study could have yielded better 
results as perimenopausal period is approximately 5-7 
years. 
CONCLUSION 
The results of the analysis imply that Sepia prescribed on 
the basis of totality of symptoms act holistically in 
relieving symptoms of menopause. Further RCT are being 
conducted to validate the effectiveness of Sepia in DDCY. 
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